Piperazine

Piperazine

SCHEMBL27664792

C1CNCCN1.O=C(O)N1CCNCC1

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.54
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA9 Q16790 1/20 0.54
CHKA P35790 1/20 0.52
CHRNB2 P17787 1/20 0.50
CHRNA3 P32297 1/20 0.50
CHRNA4 P43681 1/20 0.50
CHRNB3 Q05901 1/20 0.50
CHRNA6 Q15825 1/20 0.50
SIGMAR1 Q99720 1/20 0.48
POLB P06746 1/20 0.42
HSD11B1 P28845 1/20 0.42
RXFP1 Q9HBX9 1/20 0.38
EPHX2 P34913 1/20 0.38
HPGD P15428 1/20 0.36
HSP90AA1 P07900 1/20 0.36
ABCC1 P33527 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5031106 1.00 CA2 (0.54) CA2CA12CA1CA9CHKA
SCHEMBL28811476 1.00 CA2 (0.54) CA2CA12CA1CA9CHKA
SCHEMBL31505510 0.97 CA2 (0.52) CA2CA12CA1CA9CHKA
SCHEMBL15319 0.97
SCHEMBL6961568 0.97
SCHEMBL17100538 0.97 CA2 (0.56) CA2CA12CA1CA9CHKA
Water SCHEMBL10607939 0.94 CA2 (0.54) CA2CA12CA1CA9CHKA
Hydrochloric Acid SCHEMBL125486 0.94 CA2 (0.54) CA2CA12CA1CA9CHKA
Hydrochloric Acid SCHEMBL18116041 0.94 CA2 (0.54) CA2CA12CA1CA9CHKA
Water SCHEMBL11193463 0.94 CA2 (0.54) CA2CA12CA1CA9CHKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107708840-B Separation of CO from a gas stream 2 Method (2) 俄亥俄州创新基金会 2022-12-20 CN disclosed
CN-107108637-B Triazolopyrimidine compound and application thereof NOVARTIS AG (CH) 2019-10-29 CN disclosed
CN-108779123-A Fused tetracyclic compound, its composition and purposes 泰博生物科技有限公司 2018-11-09 CN disclosed
CN-108530428-A Substituted pyrimidine derivatives and preparation method thereof and medicinal usage 四川海思科制药有限公司 2018-09-14 CN disclosed
CN-108349969-A Substituted pyrazolo [1,5-a ] pyridine compounds as RET kinase inhibitors 阵列生物制药公司 2018-07-31 CN disclosed
CN-105175394-B Compound with active anticancer 三井有限公司 2018-06-08 CN disclosed
CN-108137510-A Compound 葛兰素史密斯克莱知识产权发展有限公司 2018-06-08 CN disclosed
CN-107709316-A The benzodioxan derivative of 2 (base of 1 heteroaryl piperazine 4) methyl 1,4 as α 2C antagonists 奥赖恩公司 2018-02-16 CN disclosed
CN-105555780-B SYK inhibitors 吉利德科学公司 2018-01-23 CN disclosed
CN-107556267-A Novel thiazole derivates class compound, its preparation method, pharmaceutical composition and its pharmaceutical applications 中国人民解放军军事医学科学院毒物药物研究所 2018-01-09 CN disclosed
CN-105555783-B Include the autotaxin inhibitors of heteroaromatic rings benzyl amide ring core 诺华股份有限公司 2017-12-01 CN disclosed
CN-105392787-B For treating and preventing the azepine oxindole of respiratory syncytial virus infection 豪夫迈·罗氏有限公司 2017-11-24 CN disclosed
CN-107344941-A Tetrahydropyrazolopyrimidine compounds 卫材R&D管理有限公司 2017-11-14 CN disclosed
CN-107108637-A Triazolopyrimidine compound and application thereof 诺华股份有限公司 2017-08-29 CN disclosed
CN-104507939-B tetrahydropyrazolopyrimidine compounds 卫材R&D管理有限公司 2017-07-25 CN disclosed
CN-105992766-A Pyrrolo [3,2-C ] pyridine derivatives as TLR inhibitors 武田药品工业株式会社 2016-10-05 CN disclosed
CN-1898222-A Substituted aryl cycloalkanol derivatives and methods of their use WYETH CORP (US) 2007-01-17 CN disclosed